Citations (123)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (19)
Savaş Güner, Mehmet Ata Gökalp, Abdurrahim Gözen, Seyyid Şerif Ünsal & Şükriye İlkay Güner. (2016) Effectiveness of etofenamate for treatment of knee osteoarthritis: a randomized controlled trial. Therapeutics and Clinical Risk Management 12, pages 1693-1699.
Read now
Read now
Margaret Noyes Essex, Regina Behar, Michael A O’Connell & Pritha Bhadra Brown. (2014) Efficacy and tolerability of celecoxib and naproxen versus placebo in Hispanic patients with knee osteoarthritis. International Journal of General Medicine 7, pages 227-235.
Read now
Read now
Allan Gibofsky, Marc C. Hochberg, Mark J. Jaros & Clarence L. Young. (2014) Efficacy and safety of low-dose submicron diclofenac for the treatment of osteoarthritis pain: a 12 week, phase 3 study. Current Medical Research and Opinion 30:9, pages 1883-1893.
Read now
Read now
Catherine Datto, Richard Hellmund & Mohd Kashif Siddiqui. (2013) Efficacy and tolerability of naproxen/esomeprazole magnesium tablets compared with non-specific NSAIDs and COX-2 inhibitors: a systematic review and network analyses. Open Access Rheumatology: Research and Reviews 5, pages 1-19.
Read now
Read now
Margaret Noyes Essex, Richard Y Zhang, Manuela F Berger, Sameer Upadhyay & Peter W Park. (2013) Safety of celecoxib compared with placebo and non-selective NSAIDs: cumulative meta-analysis of 89 randomized controlled trials. Expert Opinion on Drug Safety 12:4, pages 465-477.
Read now
Read now
K. Pavelka. (2012) A comparison of the therapeutic efficacy of diclofenac in osteoarthritis: a systematic review of randomised controlled trials. Current Medical Research and Opinion 28:1, pages 163-178.
Read now
Read now
Marina Scolnik & Gurkirpal Singh. (2011) Combination therapy versus celecoxib, a single selective COX-2 agent, to reduce gastrointestinal toxicity in arthritic patients: patient and cost-effectiveness considerations. Open Access Rheumatology: Research and Reviews 3, pages 53-62.
Read now
Read now
Alaa Rostom, Katherine Muir, Catherine Dube, Angel Lanas, Emilie Jolicoeur & Peter Tugwell. (2009) Prevention of NSAID-related upper gastrointestinal toxicity: a meta-analysis of traditional NSAIDs with gastroprotection and COX-2 inhibitors. Drug, Healthcare and Patient Safety 1, pages 47-71.
Read now
Read now
Louis Bessette, Nancy Risebrough, Nicole Mittmann, Jean-Pascal Roussy, Joanne Ho & Gergana Zlateva. (2009) Cost-utility of celecoxib use in different treatment strategies for osteoarthritis and rheumatoid arthritis from the Quebec healthcare system perspective. Journal of Medical Economics 12:3, pages 246-258.
Read now
Read now
L. E. Dahlberg, I. Holme, K. Høye & B. Ringertz. (2009) A randomized, multicentre, double‐blind, parallel‐group study to assess the adverse event‐related discontinuation rate with celecoxib and diclofenac in elderly patients with osteoarthritis. Scandinavian Journal of Rheumatology 38:2, pages 133-143.
Read now
Read now
Daniel Brzusek & David Petron. (2008) Treating knee osteoarthritis with intra-articular hyaluronans. Current Medical Research and Opinion 24:12, pages 3307-3322.
Read now
Read now
Işik Özgüney. (2008) An alternative topical treatment of osteoarthritis of the knee with cutaneous diclofenac solution. Expert Opinion on Pharmacotherapy 9:10, pages 1805-1816.
Read now
Read now
Katerina Antoniou, Michael Malamas & Alexandros A Drosos. (2007) Clinical pharmacology of celecoxib, a COX-2 selective inhibitor. Expert Opinion on Pharmacotherapy 8:11, pages 1719-1732.
Read now
Read now
C. Birbara, G. Ruoff, E. Sheldon, C. Valenzuela, A. Rodgers, R. A. Petruschke, D. J. Chang & A. M. Tershakovec. (2006) Efficacy and safety of rofecoxib 12.5 mg and celecoxib 200 mg in two similarly designed osteoarthritis studies. Current Medical Research and Opinion 22:1, pages 199-210.
Read now
Read now
Reiner Lehmann, Marek Brzosko, Petr Kopsa, Ruth Nischik, Andreas Kreiss, Helen Thurston, Stephane Litschig & Victor S. Sloan. (2005) Efficacy and tolerability of lumiracoxib 100 mg once daily in knee osteoarthritis: a 13-week, randomized, double-blind study vs. placebo and celecoxib. Current Medical Research and Opinion 21:4, pages 517-526.
Read now
Read now
Jennifer M Stephens, Christopher F Bell, Josephine M Wong, Beatriz M Peña, Seema Haider & Chris L Pashos. (2004) Value of cyclooxygenase-2 specific inhibitors in the management of osteoarthritis. Expert Review of Pharmacoeconomics & Outcomes Research 4:4, pages 441-455.
Read now
Read now
RM Pallay, W Seger, JL Adler, RE Ettlinger, EA Quaidoo, R Lipetz, K O'Brien, L Mucciola, CS Skalky, RA Petruschke, NR Bohidar & GP Geba. (2004) Etoricoxib reduced pain and disability and improved quality of life in patients with chronic low back pain: a 3 month, randomized, controlled trial. Scandinavian Journal of Rheumatology 33:4, pages 257-266.
Read now
Read now
Stanford S. Jhee, Edyta J. Frackiewicz, Dwain Tolbert, Stephen Sainati, Aziz Karim, Parvaneh P. Zolnouni & Kyung‐Eob Choi. (2004) A Pharmacokinetic, Pharmacodynamic and Safety Study of Celecoxib in Subjects with Probable Alzheimer's Disease. Clinical Research and Regulatory Affairs 21:1, pages 49-66.
Read now
Read now
Mary B Goldring. (2001) Anticytokine therapy for osteoarthritis. Expert Opinion on Biological Therapy 1:5, pages 817-829.
Read now
Read now
Articles from other publishers (104)
Silje H Sveaas, Geir Smedslund, David A Walsh & Hanne Dagfinrud. (2024) Effects of Analgesics on Self-Reported Physical Function and Walking Ability in People With Hip or Knee Osteoarthritis: A Systematic Review and Meta-Analysis. Physical Therapy 104:2.
Crossref
Crossref
Parnnaphat Luksameesate, Aree Tanavalee, Surachat Ngorsuraches & Suthira Taychakhoonavudh. (2023) Using a discrete choice experiment to elicit patients’ preferences and willingness-to-pay for knee osteoarthritis treatments in Thailand. Scientific Reports 13:1.
Crossref
Crossref
Martin Feuchtenberger, Lisa Kraus, Axel Nigg, Hendrik Schulze-Koops & Arne Schäfer. (2021) Methotrexate does not increase the risk of liver fibrosis in patients with rheumatoid arthritis: assessment by ultrasound elastography (ARFI-MetRA study). Rheumatology International 41:6, pages 1079-1087.
Crossref
Crossref
Hetao Huang, Minghui Luo, Haodong Liang, Jianke Pan, Weiyi Yang, Lingfeng Zeng, Guihong Liang, Senrong Hou, Jinlong Zhao & Jun Liu. (2021) Meta-analysis Comparing Celecoxib with Diclofenac Sodium in Patients with Knee Osteoarthritis. Pain Medicine 22:2, pages 352-362.
Crossref
Crossref
Ziqin Cao, Jian Zhou, Zeling Long, Yihan Li, Jingjing Sun, Yingquan Luo & Wanchun Wang. (2020) Targeting nerve growth factor, a new option for treatment of osteoarthritis: a network meta-analysis of comparative efficacy and safety with traditional drugs. Aging 13:1, pages 1051-1070.
Crossref
Crossref
Christopher Vannabouathong, Meng Zhu, Yaping Chang & Mohit Bhandari. (2021) Can Medical Cannabis Therapies be Cost-Effective in the Non-Surgical Management of Chronic Knee Pain?. Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders 14, pages 117954412110024.
Crossref
Crossref
Ziqin Cao, Yajia Li, Wanchun Wang, Shuo Jie, Xuantao Hu, Jian Zhou, Tong Wu, Dilihumaer Aili, Zeling Long, Yihan Li, Pengcheng Dou & Ren Wu. (2020) Is Lutikizumab, an Anti–Interleukin-1α/β Dual Variable Domain Immunoglobulin, efficacious for Osteoarthritis? Results from a bayesian network meta-analysis. BioMed Research International 2020, pages 1-10.
Crossref
Crossref
Min-Gyue Park, Jae-Doo Yoo & Kyu-Ho Lee. (2020) Current Guidelines for Non-Steroidal Anti-Inflammatory Drugs. Journal of the Korean Orthopaedic Association 55:1, pages 9.
Crossref
Crossref
Moe H. Kyaw, Alaa Rostom, Katherine Muir, Catherine Dubé, Emilie Jolicoeur, Michel Boucher, Peter Tugwell, George Wells & Francis K.L. Chan. 2019. Evidence‐based Gastroenterology and Hepatology 4e. Evidence‐based Gastroenterology and Hepatology 4e
86
109
.
Elizabeth Curtis, Nicholas Fuggle, Sarah Shaw, Laura Spooner, Georgia Ntani, Camille Parsons, Nadia Corp, Germain Honvo, Janis Baird, Stefania Maggi, Elaine Dennison, Olivier Bruyère, Jean-Yves Reginster & Cyrus Cooper. (2019) Safety of Cyclooxygenase-2 Inhibitors in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis. Drugs & Aging 36:S1, pages 25-44.
Crossref
Crossref
A. E. Karateev. (2019) How effective is the average therapeutic dose of a nonsteroidal anti-inflammatory drug in osteoarthritis?. Modern Rheumatology Journal 13:1, pages 108-113.
Crossref
Crossref
Chris Walker. (2018) Are All Oral COX-2 Selective Inhibitors the Same? A Consideration of Celecoxib, Etoricoxib, and Diclofenac. International Journal of Rheumatology 2018, pages 1-12.
Crossref
Crossref
Daiany P. B. da Silva, Iziara F. Florentino, Dayane M. da Silva, Roberta C. Lino, Carina S. Cardoso, Lorrane K. S. Moreira, Géssica A. Vasconcelos, Daniela C. Vinhal, Anna C. D. Cardoso, Bianca Villavicencio, Hugo Verli, Boniek G. Vaz, Luciano M. Lião, Luiz C. da Cunha, Ricardo Menegatti & Elson A. Costa. (2018) Molecular docking and pharmacological/toxicological assessment of a new compound designed from celecoxib and paracetamol by molecular hybridization. Inflammopharmacology 26:5, pages 1189-1206.
Crossref
Crossref
David S. Jevsevar, Peter B. Shores, Kyle Mullen, Danielle M. Schulte, Gregory A. Brown & Deborah S. Cummins. (2018) Mixed Treatment Comparisons for Nonsurgical Treatment of Knee Osteoarthritis: A Network Meta-analysis. Journal of the American Academy of Orthopaedic Surgeons 26:9, pages 325-336.
Crossref
Crossref
Pajaree Sriuttha, Buntitabhon Sirichanchuen & Unchalee Permsuwan. (2018) Hepatotoxicity of Nonsteroidal Anti-Inflammatory Drugs: A Systematic Review of Randomized Controlled Trials. International Journal of Hepatology 2018, pages 1-13.
Crossref
Crossref
Livia Puljak, Ana Marin, Davorka Vrdoljak, Filipa Markotic, Ana Utrobicic & Peter Tugwell. (2017) Celecoxib for osteoarthritis. Cochrane Database of Systematic Reviews 2017:7.
Crossref
Crossref
Ana C Gordo, Chris Walker, Beatriz Armada & Duo Zhou. (2017) Efficacy of celecoxib versus ibuprofen for the treatment of patients with osteoarthritis of the knee: A randomized double-blind, non-inferiority trial. Journal of International Medical Research 45:1, pages 59-74.
Crossref
Crossref
Toby O Smith, Kun Zou, Natasya Abdullah, Xi Chen, Sarah R Kingsbury, Michael Doherty, Weiya Zhang & Philip G Conaghan. (2016) Does flare trial design affect the effect size of non-steroidal anti-inflammatory drugs in symptomatic osteoarthritis? A systematic review and meta-analysis. Annals of the Rheumatic Diseases 75:11, pages 1971-1978.
Crossref
Crossref
Chris Walker, Margaret N Essex, Chunming Li & Peter W Park. (2016) Celecoxib versus diclofenac for the treatment of ankylosing spondylitis: 12-week randomized study in Norwegian patients. Journal of International Medical Research 44:3, pages 483-495.
Crossref
Crossref
Marc C Hochberg, Johanne Martel-Pelletier, Jordi Monfort, Ingrid Möller, Juan Ramón Castillo, Nigel Arden, Francis Berenbaum, Francisco J Blanco, Philip G Conaghan, Gema Doménech, Yves Henrotin, Thomas Pap, Pascal Richette, Allen Sawitzke, Patrick du Souich & Jean-Pierre Pelletier. (2016) Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib. Annals of the Rheumatic Diseases 75:1, pages 37-44.
Crossref
Crossref
Raveendhara R. BannuruTimothy E. McAlindonMatthew C. SullivanJohn B. WongDavid M. KentChristopher H. Schmid. (2015) Effectiveness and Implications of Alternative Placebo Treatments. Annals of Internal Medicine 163:5, pages 365-372.
Crossref
Crossref
Chao Zeng, Jie Wei, Hui Li, Tuo Yang, Shu-guang Gao, Yu-sheng Li, Yi-lin Xiong, Wen-feng Xiao, Wei Luo, Tu-bao Yang & Guang-hua Lei. (2015) Comparison between 200 mg QD and 100 mg BID oral celecoxib in the treatment of knee or hip osteoarthritis. Scientific Reports 5:1.
Crossref
Crossref
K.D. Rainsford & Ingvar Bjarnason. 2015. Ibuprofen. Ibuprofen
363
429
.
Patompong Ungprasert, Wisit Cheungpasitporn, Cynthia S. Crowson & Eric L. Matteson. (2015) Individual non-steroidal anti-inflammatory drugs and risk of acute kidney injury: A systematic review and meta-analysis of observational studies. European Journal of Internal Medicine 26:4, pages 285-291.
Crossref
Crossref
Wan-Hee Yoo, Han-Gyul Yoo, Sung-Hwan Park, Han-joo Baek, Yun Jong Lee, Seung Cheol Shim, Seong Wook Kang, Hyun Ah Kim, Jung Soo Song, Chang Hee Suh, Sung Jae Choi, Bo Young Yoon, Dong Nyeon Tae, Hyun Sook Ko & Yeong-Wook Song. (2014) Efficacy and safety of PG201 (Layla®) and celecoxib in the treatment of symptomatic knee osteoarthritis: a double-blinded, randomized, multi-center, active drug comparative, parallel-group, non-inferiority, phase III study. Rheumatology International 34:10, pages 1369-1378.
Crossref
Crossref
John Fabule & Ade Adebajo. (2014) Comparative evaluation of cardiovascular outcomes in patients with osteoarthritis and rheumatoid arthritis on recommended doses of nonsteroidal anti-inflammatory drugs. Therapeutic Advances in Musculoskeletal Disease 6:4, pages 111-130.
Crossref
Crossref
Atsushi Hirayama, Norio Tanahashi, Hiroyuki Daida, Naoki Ishiguro, Motohiko Chachin, Toshihiko Sugioka, Shinichi Kawai & on behalf of all ACCEPT study investigators in Japan. (2014) Assessing the Cardiovascular Risk Between Celecoxib and Nonselective Nonsteroidal Antiinflammatory Drugs in Patients With Rheumatoid Arthritis and Osteoarthritis. Circulation Journal 78:1, pages 194-205.
Crossref
Crossref
Herbert L. Kellner, Chunming Li & Margaret N. Essex. (2013) Celecoxib and Diclofenac Plus Omeprazole are Similarly Effective in the Treatment of Arthritis in Patients at High GI Risk in the CONDOR Trial§. The Open Rheumatology Journal 7:1, pages 96-100.
Crossref
Crossref
Robert C. WoodIIIIII, Jarrett E. Wyatt, Kenny W. Bullins, Angela V. Hanley, Gregory A. Hanley, James W. Denham, Peter C. Panus & Sam Harirforoosh. (2013) Effects of rebamipide on nephrotoxicity associated with selected NSAIDs in rats. European Journal of Pharmacology 720:1-3, pages 138-146.
Crossref
Crossref
P. G. Conaghan, J. Dickson, W. Bolten, G. Cevc & M. Rother. (2013) A multicentre, randomized, placebo- and active-controlled trial comparing the efficacy and safety of topical ketoprofen in Transfersome gel (IDEA-033) with ketoprofen-free vehicle (TDT 064) and oral celecoxib for knee pain associated with osteoarthritis. Rheumatology 52:7, pages 1303-1312.
Crossref
Crossref
Ting Li, Shun-le Chen, Qing Dai, Xing-hai Han, Zhan-guo Li, Dong-hai Wu, Xiao Zhang, Jie-ruo Gu, Nan-ping Yang, Ling-yun Sun, Miu-jia Zhang, Xing-fu Li & Chun-de Bao. (2013) Etoricoxib versus indometacin in the treatment of Chinese patients with acute gouty arthritis: a randomized double-blind trial. Chinese Medical Journal 126:10, pages 1867-1871.
Crossref
Crossref
R. Norman Harden, Gila Wallach, Christine M. Gagnon, Arzhang Zereshki, Ai Mukai, Meryem Saracoglu, Maxine M. Kuroda, Joseph R. Graciosa & Stephen Bruehl. (2013) The Osteoarthritis Knee Model: Psychophysical Characteristics and Putative Outcomes. The Journal of Pain 14:3, pages 281-289.
Crossref
Crossref
Ade Adebajo. (2012) Non-steroidal anti-inflammatory drugs for the treatment of pain and immobility-associated osteoarthritis: consensus guidance for primary care. BMC Family Practice 13:1.
Crossref
Crossref
Mn Essex, P Bhadra & Gh Sands. (2012) Efficacy and Tolerability of Celecoxib versus Naproxen in Patients with Osteoarthritis of the Knee: A Randomized, Double-Blind, Double-Dummy Trial. Journal of International Medical Research 40:4, pages 1357-1370.
Crossref
Crossref
VIBEKE STRAND, LEE S. SIMON, MAXIME DOUGADOS, GEORGE H. SANDS, PRITHA BHADRA, AURORA BREAZNA & JEFF IMMITT. (2011) Treatment of Osteoarthritis with Continuous Versus Intermittent Celecoxib. The Journal of Rheumatology 38:12, pages 2625-2634.
Crossref
Crossref
Paul L. McCormack. (2011) Celecoxib. Drugs 71:18, pages 2457-2489.
Crossref
Crossref
B.C. Garrido López, F. Navarro Sarabia & E.M. Montero Martín. (2011) Antiinflamatorios no esteroideos: farmacodinámica, reacciones adversas e indicaciones en reumatología. Medicine - Programa de Formación Médica Continuada Acreditado 10:92, pages 6255-6261.
Crossref
Crossref
Rui Luo, Gang Liu, Wei Liu, Fuxing Pei, Zongke Zhou, Jian Li, Bin Shen, Pengde Kang, Qibing Xie & Xin Ma. (2010) Efficacy of celecoxib, meloxicam and paracetamol in elderly Kashin-Beck Disease (KBD) patients. International Orthopaedics 35:9, pages 1409-1414.
Crossref
Crossref
Alaa Rostom, Katherine Muir, Catherine Dubé, Emilie Jolicoeur, Michel Boucher, Peter Tugwell & George Wells. 2010. Evidence‐Based Gastroenterology and Hepatology. Evidence‐Based Gastroenterology and Hepatology
139
164
.
S. Trijau, J. Avouac, C. Escalas, L. Gossec & M. Dougados. (2010) Influence of flare design on symptomatic efficacy of non-steroidal anti-inflammatory drugs in osteoarthritis: a meta-analysis of randomized placebo-controlled trials. Osteoarthritis and Cartilage 18:8, pages 1012-1018.
Crossref
Crossref
J. W. J. Bijlsma. (2010) Patient benefit-risk in arthritis--a rheumatologist's perspective. Rheumatology 49:suppl 2, pages ii11-ii17.
Crossref
Crossref
Michael J. BattistoneAllen Dale Sawitzke. (2010) Celecoxib in the Treatment of Osteoarthritis. Clinical Medicine Insights: Therapeutics 2, pages CMT.S1967.
Crossref
Crossref
JB O'Donnell, EF Ekman, WM Spalding, P Bhadra, D McCabe & MF Berger. (2009) The Effectiveness of a Weak Opioid Medication versus a Cyclo-Oxygenase-2 (COX-2) Selective Non-Steroidal Anti-Inflammatory Drug in Treating Flare-Up of Chronic Low-Back Pain: Results from Two Randomized, Double-Blind, 6-Week Studies. Journal of International Medical Research 37:6, pages 1789-1802.
Crossref
Crossref
Loren Laine, William B. White, Alaa Rostom & Marc Hochberg. (2008) COX-2 Selective Inhibitors in the Treatment of Osteoarthritis. Seminars in Arthritis and Rheumatism 38:3, pages 165-187.
Crossref
Crossref
Alan Kivitz, Michael Fairfax, Eric A. Sheldon, Qinfang Xiang, Beverly A. Jones, Arnold R. Gammaitoni & Errol M. Gould. (2008) Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: Post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adults. Clinical Therapeutics 30:12, pages 2366-2377.
Crossref
Crossref
. (2008) Recommendations for use of selective and nonselective nonsteroidal antiinflammatory drugs: An American College of Rheumatology white paper. Arthritis Care & Research 59:8, pages 1058-1073.
Crossref
Crossref
Shaojun Shi & Ulrich Klotz. (2007) Clinical use and pharmacological properties of selective COX-2 inhibitors. European Journal of Clinical Pharmacology 64:3, pages 233-252.
Crossref
Crossref
Soo Soo LIM, Peng Chiong TAN, Jayanthi Karen SOCKALINGAM & Siti Zawiah OMAR. (2008) Oral celecoxib versus oral diclofenac for post‐perineal repair analgesia after spontaneous vaginal birth: A randomised trial. Australian and New Zealand Journal of Obstetrics and Gynaecology 48:1, pages 71-77.
Crossref
Crossref
Wendy L. Wright. (2008) Management of mild-to-moderate osteoarthritis: Effective intervention by the nurse practitioner. The Journal for Nurse Practitioners 4:1, pages 25-34.
Crossref
Crossref
Paul Emery, Tamas Koncz, Sharon Pan & Simon Lowry. (2008) Analgesic effectiveness of celecoxib and diclofenac in patients with osteoarthritis of the hip requiring joint replacement surgery: a 12-week, multicenter, randomized, double-blind, parallel-group, double-dummy, noninferiority study. Clinical Therapeutics 30:1, pages 70-83.
Crossref
Crossref
Alaa Rostom, Katherine Muir, Catherine Dubé, Emilie Jolicoeur, Michel Boucher, Janet Joyce, Peter Tugwell & George W. Wells. (2007) Gastrointestinal Safety of Cyclooxygenase-2 Inhibitors: A Cochrane Collaboration Systematic Review. Clinical Gastroenterology and Hepatology 5:7, pages 818-828.e5.
Crossref
Crossref
Jan Magnus Bjordal, Atle Klovning, Anne Elisabeth Ljunggren & Lars Slørdal. (2012) Short‐term efficacy of pharmacotherapeutic interventions in osteoarthritic knee pain: A meta‐analysis of randomised placebo‐controlled trials. European Journal of Pain 11:2, pages 125-138.
Crossref
Crossref
Bernard Bannwarth. (2007) Transdermal fentanyl in patients with osteoarthritis: Comment on the article by Langford et al. Arthritis & Rheumatism 56:2, pages 697-698.
Crossref
Crossref
L-C. Chen & D. M. Ashcroft. (2006) Do selective COX-2 inhibitors increase the risk of cerebrovascular events? A meta-analysis of randomized controlled trials. Journal of Clinical Pharmacy and Therapeutics 31:6, pages 565-576.
Crossref
Crossref
Maggi Banning. (2006) The use of topical diclofenac for pain in osteoarthritis of the knee: a review. British Journal of Community Nursing 11:11, pages 487-492.
Crossref
Crossref
Todd P. Stitik, Eric Altschuler & Patrick M. Foye. (2006) Pharmacotherapy of Osteoarthritis. American Journal of Physical Medicine & Rehabilitation 85:Supplement, pages S15-S28.
Crossref
Crossref
Chin Hur, Andrew T Chan, Angela C Tramontano & G Scott Gazelle. (2016) Coxibs Versus Combination NSAID and PPI Therapy for Chronic Pain: An Exploration of the Risks, Benefits, and Costs. Annals of Pharmacotherapy 40:6, pages 1052-1063.
Crossref
Crossref
Brennan M.R. Spiegel, Mary Farid, Gareth S. Dulai, Ian M. Gralnek & Fasiha Kanwal. (2006) Comparing Rates of Dyspepsia with Coxibs vs NSAID+PPI: A Meta-Analysis. The American Journal of Medicine 119:5, pages 448.e27-448.e36.
Crossref
Crossref
Brent Caldwell, Sarah Aldington, Mark Weatherall, Philippa Shirtcliffe & Richard Beasley. (2017) Risk of Cardiovascular Events and Celecoxib: a Systematic Review and Meta-Analysis. Journal of the Royal Society of Medicine 99:3, pages 132-140.
Crossref
Crossref
Jay L. Goldstein, James Aisenberg, Frank Lanza, Howard Schwartz, George H. Sands, Manuela F. Berger & Sharon Pan. (2006) A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years. Clinical Therapeutics 28:3, pages 340-351.
Crossref
Crossref
Roy Fleischmann, Eric Sheldon, José Maldonado-Cocco, Dipen Dutta, Sue Yu & Victor S. Sloan. (2005) Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a prospective randomized 13-week study versus placebo and celecoxib. Clinical Rheumatology 25:1, pages 42-53.
Crossref
Crossref
Gary W. Williams. (2005) An update on nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors. Current Pain and Headache Reports 9:6, pages 377-389.
Crossref
Crossref
Chin Lee, Elke Hunsche, Robert Balshaw, Sheldon X. Kong & Thomas J. Schnitzer. (2005) Need for common internal controls when assessing the relative efficacy of pharmacologic agents using a meta-analytic approach: Case study of cyclooxygenase 2-selective inhibitors for the treatment of osteoarthritis. Arthritis & Rheumatism 53:4, pages 510-518.
Crossref
Crossref
Kathryn Burks. (2005) Osteoarthritis IN OLDER ADULTS: Current Treatments. Journal of Gerontological Nursing 31:5, pages 11-19.
Crossref
Crossref
Alan Muskett, W Henry BarberVV & William C. Lineaweaver. (2005) The Plastic Surgeon??s Guide to Drugs Affecting Hemostasis. Annals of Plastic Surgery 54:5, pages 570-576.
Crossref
Crossref
Alaa Rostom, Lawrence Goldkind & Loren Laine. (2005) Nonsteroidal Anti-Inflammatory Drugs and Hepatic Toxicity: A Systematic Review of Randomized Controlled Trials in Arthritis Patients. Clinical Gastroenterology and Hepatology 3:5, pages 489-498.
Crossref
Crossref
Brennan M. R. Spiegel, Chiun‐Fang Chiou & Joshua J. Ofman. (2005) Minimizing complications from nonsteroidal antiinflammatory drugs: Cost‐effectiveness of competing strategies in varying risk groups. Arthritis Care & Research 53:2, pages 185-197.
Crossref
Crossref
G. M. Eisen, J. L. Goldstein, D. B. Hanna & D. A. Rublee. (2005) Meta‐analysis: upper gastrointestinal tolerability of valdecoxib, a cyclooxygenase‐2‐specific inhibitor, compared with nonspecific nonsteroidal anti‐inflammatory drugs among patients with osteoarthritis and rheumatoid arthritis. Alimentary Pharmacology & Therapeutics 21:5, pages 591-598.
Crossref
Crossref
Marc Fajardo & Paul E Di Cesare. (2005) Disease-Modifying Therapies for Osteoarthritis. Drugs & Aging 22:2, pages 141-161.
Crossref
Crossref
Eric Sheldon, Andre Beaulieu, Zorba Paster, Dipen Dutta, Sue Yu & Victor S. Sloan. (2005) Efficacy and tolerability of lumiracoxib in the treatmentof osteoarthritis of the knee: A 13-week, randomized, double-blind comparison with celecoxib and placebo. Clinical Therapeutics 27:1, pages 64-77.
Crossref
Crossref
Steven A. Mazzuca, Mark C. Page, Russell D. Meldrum, Kenneth D. Brandt & Satham Petty‐Saphon. (2004) Pilot study of the effects of a heat‐retaining knee sleeve on joint pain, stiffness, and function in patients with knee osteoarthritis. Arthritis Care & Research 51:5, pages 716-721.
Crossref
Crossref
Thomas J. Schnitzer, Jannie Beier, Piet Geusens, Paul Hasler, Sanjay K. Patel, Ingo Senftleber, Xavier Gitton, Alan Moore, Victor S. Sloan & Gyula Poór. (2004) Efficacy and safety of four doses of lumiracoxib versus diclofenac in patients with knee or hip primary osteoarthritis: A phase II, four‐week, multicenter, randomized, double‐blind, placebo‐controlled trial. Arthritis Care & Research 51:4, pages 549-557.
Crossref
Crossref
Kenneth G. Saag, Jason J. Olivieri, Fausto Patino, Ted R. Mikuls, Jeroan J. Allison & Catherine H. MacLean. (2004) Measuring quality in arthritis care: The Arthritis Foundation's quality indicator set for analgesics. Arthritis Care & Research 51:3, pages 337-349.
Crossref
Crossref
. (2004) NIH Consensus Statement on Total Knee Replacement December 8-10, 2003*. The Journal of Bone and Joint Surgery-American Volume 86:6, pages 1328-1335.
Crossref
Crossref
Evan F. Ekman & Andrew L. Koman. (2004) Acute Pain Following Musculoskeletal Injuries and Orthopaedic Surgery. The Journal of Bone and Joint Surgery-American Volume 86:6, pages 1316-1327.
Crossref
Crossref
Keri L. Fakata. (2004) Anti-inflammatory agents for the treatment of musculoskeletal pain and arthritis. Current Pain and Headache Reports 8:3, pages 173-177.
Crossref
Crossref
MK Ho & CH Chung. (2017) A Prospective, Randomised Clinical Trial Comparing Oral Diclofenac Potassium and Intramuscular Diclofenac Sodium in Acute Pain Relief. Hong Kong Journal of Emergency Medicine 11:2, pages 69-77.
Crossref
Crossref
G??rald Mongin, Vladimir Yakusevich, Adorjan K??pe, Nadezhda Shostak, Eduard Pikhlak, Laszlo Popd??n, Judit Simon, Catherine Navarro, Louise Fortier, Sybil Robertson & Sylvie Bouchard. (2004) Efficacy and Safety Assessment of a Novel Once-Daily Tablet Formulation of Tramadol. Clinical Drug Investigation 24:9, pages 545-558.
Crossref
Crossref
Karin Martin, Bernard Bégaud, Philippe Latry, Ghada Miremont‐Salamé, Annie Fourrier & Nicholas Moore. (2003) Differences between clinical trials and postmarketing use. British Journal of Clinical Pharmacology 57:1, pages 86-92.
Crossref
Crossref
Frank Degner. 2004. COX-2 Inhibitors. COX-2 Inhibitors
133
148
.
Sara Jane Andersen. (2003) Cyclooxygenase-2 inhibitor treatment of older osteoarthritis patients. Comprehensive Therapy 29:4, pages 215-223.
Crossref
Crossref
Tankred Wegener & Niels‐Peter Lüpke. (2003)
Treatment of patients with arthrosis of hip or knee with an aqueous extract of Devil's Claw (
Harpagophytum procumbens
DC.)
. Phytotherapy Research 17:10, pages 1165-1172.
Crossref
Crossref
Allan Gibofsky, Gary W. Williams, Frank McKenna & John G. Fort. (2003) Comparing the efficacy of cyclooxygenase 2–specific inhibitors in treating osteoarthritis: Appropriate trial design considerations and results of a randomized, placebo‐controlled trial. Arthritis & Rheumatism 48:11, pages 3102-3111.
Crossref
Crossref
Keri L. Fakata & Arthur G. Lipman. (2003) Pharmacotherapy for pain in rheumatologic conditions: The neuropathic component. Current Pain and Headache Reports 7:3, pages 197-205.
Crossref
Crossref
P Bertin, J-M Béhier, E Noël & J-L Leroux. (2003) Celecoxib is as Efficacious as Naproxen in the Management of Acute Shoulder Pain. Journal of International Medical Research 31:2, pages 102-112.
Crossref
Crossref
Carlo Lucioni, S. Chiroli, D. Roggeri & G. Annoni. (2013) Analisi di costo della terapia con celecoxib vs FANS tradizionali nell’artrosi in ItaliaCost-analysis of a 6-week cycle of therapy with celecoxib vs conventional NSAIDs in ostheoarthritis in Italy. PharmacoEconomics Italian Research Articles 5:1, pages 23-34.
Crossref
Crossref
Tore K Kvien & Kirsten Viktil. (2003) Pharmacotherapy for regional musculoskeletal pain. Best Practice & Research Clinical Rheumatology 17:1, pages 137-150.
Crossref
Crossref
Louis Kuritzky & Arthur Weaver. (2003) Advances in Rheumatology. Journal of Pain and Symptom Management 25:2, pages 6-20.
Crossref
Crossref
Kenneth Brandt. (2003) Paracetamol in the Treatment of Osteoarthritis Pain. Drugs 63:Special Issue 2, pages 23-38.
Crossref
Crossref
Roland W. Moskowitz, Abraham Sunshine, Andrew Brugger, James B. Lefkowith, William W. Zhao & G. Steven Geis. (2003) American Pain Society Pain Questionnaire and Other Pain Measures in the Assessment of Osteoarthritis Pain: A Pooled Analysis of Three Celecoxib Pivotal Studies. American Journal of Therapeutics 10:1, pages 12-20.
Crossref
Crossref
Elizabeth A. Tindall, John T. Sharp, Aimee Burr, T.Kirsten Katz, Carl B. Wallemark, Kenneth Verburg & James B. Lefkowith. (2002) A 12-month, multicenter, prospective, open-label trial of radiographic analysis of disease progression in osteoarthritis of the knee or hip in patients receiving celecoxib. Clinical Therapeutics 24:12, pages 2051-2063.
Crossref
Crossref
Ellen C. Hayes & John A. Rock. (2002) COX-2 Inhibitors and Their Role in Gynecology. Obstetrical & Gynecological Survey 57:11, pages 768-780.
Crossref
Crossref
Ronald W. Jubb. (2002) Oral and intra-articular remedies: Review of papers published from March 2001 to February 2002. Current Opinion in Rheumatology 14:5, pages 597-602.
Crossref
Crossref
LLM Weckx, JE Ruiz, J Duperly, GA Martínez Mendizabal, MBG Rausis, SL Piltcher, M Saffer, C Matsuyama, S Levy & JG Fort. (2016) Efficacy of Celecoxib in Treating Symptoms of Viral Pharyngitis: A Double-Blind, Randomized Study of Celecoxib versus Diclofenac. Journal of International Medical Research 30:2, pages 185-194.
Crossref
Crossref
Camilla I. SvenssonTony L. Yaksh. (2002) The Spinal Phospholipase-Cyclooxygenase-Prostanoid Cascade in Nociceptive Processing. Annual Review of Pharmacology and Toxicology 42:1, pages 553-583.
Crossref
Crossref
Robert W. McMurray & Kenneth J. Hardy. (2002) Cox-2 Inhibitors: Today and Tomorrow. The American Journal of the Medical Sciences 323:4, pages 181-189.
Crossref
Crossref
J. L. Goldstein, G. M. Eisen, T. A. Burke, B. M. Peña, J. Lefkowith & G. S. Geis. (2002) Dyspepsia tolerability from the patients' perspective: a comparison of celecoxib with diclofenac. Alimentary Pharmacology & Therapeutics 16:4, pages 819-827.
Crossref
Crossref
Vijay Vad, Hoyman M. Hong, Michael Zazzali, Nergis Agi & Dilshaad Basrai. (2002) Exercise Recommendations in Athletes with Early Osteoarthritis of the Knee. Sports Medicine 32:11, pages 729-739.
Crossref
Crossref
D J. Rowbotham. (2002) COX-2-selective inhibitors: clinical relevance in surgical and acute pain. European Journal of Anaesthesiology 19:Supplement 25, pages 11-20.
Crossref
Crossref
M. Solca. (2002) Acute pain management: unmet needs and new advances in pain management. European Journal of Anaesthesiology 19:Supplement 25, pages 3-10.
Crossref
Crossref
Antonio Vallano, Roser Llop & Montserrat Bosch. (2002) Beneficios y riesgos de los antiinflamatorios no esteroides inhibidores selectivos de la ciclooxigenasa-2. Medicina Clínica 119:11, pages 429-434.
Crossref
Crossref
AJ Kivitz, RW Moskowitz, E Woods, RC Hubbard, KM Verburg, JB Lefkowith & GS Geis. (2016) Comparative Efficacy and Safety of Celecoxib and Naproxen in the Treatment of Osteoarthritis of the Hip. Journal of International Medical Research 29:6, pages 467-479.
Crossref
Crossref
Marc C. Hochberg. (2001) What a difference a year makes: Reflections on the ACR recommendations for the medical management of osteoarthritis. Current Rheumatology Reports 3:6, pages 473-478.
Crossref
Crossref
Frank McKenna, Arthur Weaver, Justus J. Fiechtner, Alfonso E. Bello & John G. Fort. (2001) COX-2 Specific Inhibitors in the Management of Osteoarthritis of the Knee: A Placebo-Controlled, Randomized, Double-Blind Study. JCR: Journal of Clinical Rheumatology 7:3, pages 151-159.
Crossref
Crossref